News Article

Amethyst Healthcare has acquired Júlio Teixeira, a well-established provider of radiotherapy services operating in Porto and Braga. This acquisition forms part of its strategic expansion in Western Europe and will strengthen the group’s capacity to deliver advanced radiotherapy care in Portugal.

Announced on October 6, 2025, the deal represents a significant strategic milestone in Amethyst’s expansion across Western Europe and further solidifies its position as the largest private radiotherapy provider in Europe, serving more than 50,000 patients annually across 17 specialized centres.

Júlio Teixeira will continue to provide uninterrupted patient care while its clinical and operational teams are integrated into Amethyst’s governance and quality frameworks. The acquisition gives it access to pan-European clinical best practice, structured professional development, and targeted capital investment to support ongoing service expansion.

Amethyst delivers non-surgical oncology treatment across the international Cancer Care market in Austria, France, Italy, Poland, Romania and the UK, operating 17 specialist centres, comprising 34 Linear Accelerators (Linacs) and two Gamma Knife Radiosurgery centres.